Longer Telomere Length of T lymphocytes in Patients with Early and Chronic Psychosis

키워드

참고문헌 (56)

1. Blackburn EH, "Telomeres and telomerase : their mechanisms of action and the effects of altering their functions", FEBS Lett, 579, pp.859~862 (2005)
2. Blasco MA, "Telomeres and human disease: ageing, cancer and beyond", Nat Rev Genet, 6, pp.611~622 (2005)
3. von Zglinicki T, "Telomeres as biomarkers for ageing and age-related diseases", Curr Mol Med, 5, pp.197~203 (2005)
4. Thomas P, "Telomere length in white blood cells, buccal cells and brain tissue and its variation with ageing and Alzheimer’s disease", Mech Ageing Dev, 129, pp.183~190 (2008)
5. Epel ES, "Accelerated telomere shortening in response to life stress", Proc Natl Acad Sci U S A, 101, pp.17312~17315 (2004)
6. O’Donovan A, "Pessimism correlates with leukocyte telomere shortness and elevated interleukin-6 in postmenopausal women", Brain Behav Immun, 23, pp.446~449 (2009)
7. Brydon L, "Hostility and cellular aging in men from the Whitehall II cohort", Biol Psychiatry, 71, pp.767~773 (2012)
8. Simon NM, "Telomere shortening and mood disorders : preliminary support for a chronic stress model of accelerated aging", Biol Psychiatry, 60, pp.432~435 (2006)
9. Shalev I, "Internalizing disorders and leukocyte telomere erosion: a prospective study of depression, generalized anxiety disorder and post-traumatic stress disorder", Mol Psychiatry, 19, pp.1163~1170 (2014)
10. Kao HT, "Rapid telomere erosion in schizophrenia", Mol Psychiatry, 13, pp.118~119 (2008)
11. Flatow J, "Meta-analysis of oxidative stress in schizophrenia", Biol Psychiatry, 74, pp.400~409 (2013)
12. Mather KA, "Is telomere length a biomarker of aging? A review", J Gerontol A Biol Sci Med Sci, 66, pp.202~213 (2011)
13. Yu WY, "Short telomeres in patients with chronic schizophrenia who show a poor response to treatment", J Psychiatry Neurosci, 33, pp.244~247 (2008)
14. Fernandez-Egea E, "Telomere length and pulse pressure in newly diagnosed, antipsychotic-naive patients with nonaffective psychosis", Schizophr Bull, 35, pp.437~442 (2009)
15. Kota LN, "Shortened telomere in unremitted schizophrenia", Psychiatry Clin Neurosci, 69, pp.292~297 (2015)
16. Zhang D, "Cerebellar telomere length and psychiatric disorders", Behav Genet, 40, pp.250~254 (2010)
17. Mansour H, "Does telomere length mediate associations between inbreeding and increased risk for bipolar I disorder and schizophrenia?", Psychiatry Res, 188, pp.129~132 (2011)
18. Malaspina D, "Telomere length, family history, and paternal age in schizophrenia", Mol Genet Genomic Med, 2, pp.326~331 (2014)
19. Nieratschker V, "Longer telomere length in patients with schizophrenia", Schizophr Res, 149, pp.116~120 (2013)
20. Lin J, "Systematic and cell type-specific telomere length changes in subsets of lymphocytes", J Immunol Res, 2016, pp.5371050~ (2016)
21. Levite M, "Neurotransmitters activate T-cells and elicit crucial functions via neurotransmitter receptors", Curr Opin Pharmacol, 8, pp.460~471 (2008)
22. Brait VH, "Importance of T lymphocytes in brain injury, immunodeficiency, and recovery after cerebral ischemia", J Cereb Blood Flow Metab, 32, pp.598~611 (2012)
23. First MB, "Structured clinical interview for DSM-IV axis I disorders, research version" (1997), New York State Psychiatric Institute
24. Han OS, "Structured clinical interview for DSM-IV axis I disorders, research version" (2000), Korea Hana Medical Publishing
25. NP), "Structured clinical interview for DSM-IV axis I disorders, research version, non-patient edition (SCID-I", pp.1997, First MB
26. Kay SR, "The positive and negative syndrome scale(PANSS)for schizophrenia", Schizophr Bull, 13, pp.261~276 (1987)
27. Addington D, "Assessing depression in schizophrenia: the Calgary Depression Scale", Br J Psychiatry Suppl, (22), pp.39~44 (1993)
28. Haro JM, "The Clinical Global Impression-Schizophrenia scale: a simple instrument to measure the diversity of symptoms present in schizophrenia", Acta Psychiatr Scand Suppl, (416), pp.16~23 (2003)
29. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, "Executive summary of the third report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)", JAMA, 285, pp.2486~2497 (2001)
30. Hales RE, "The American Psychiatric Publishing textbook of psychiatry" (2008), American Psychiatric Pub
31. FLB 457 in schizophrenia, "J Clin Psychopharmacol", 2013, 162~169
32. Hori H, "Effect of blonanserin on cognitive and social function in acute phase Japanese schizophrenia compared with risperidone", Neuropsychiatr Dis Treat, 10, pp.527~533 (2014)
33. Arakawa R, "Dose-finding study of paliperidone ER based on striatal and extrastriatal dopamine D2 receptor occupancy in patients with schizophrenia", Psychopharmacology(Berl), 197, pp.229~235 (2008)
34. Nyberg S, "Suggested minimal effective dose of risperidone based on PET-measured D2 and 5-HT2A receptor occupancy in schizophrenic patients", Am J Psychiatry, 156, pp.869~875 (1999)
35. Cawthon RM, "Telomere measurement by quantitative PCR", Nucleic Acids Res, 30, pp.e47~ (2002)
36. Kananen L, "Childhood adversities are associated with shorter telomere length at adult age both in individuals with an anxiety disorder and controls", PLoS One, 5, pp.e10826~ (2010)
37. Shalev I, "Exposure to violence during childhood is associated with telomere erosion from 5 to 10 years of age : a longitudinal study", Mol Psychiatry, 18, pp.576~581 (2013)
38. Wikgren M, "APOE 4 is associated with longer telomeres, and longer telomeres among 4 carriers predicts worse episodic memory", Neurobiol Aging, 33, pp.335~344 (2012)
39. Wikgren M, "Longer leukocyte telomere length is associated with smaller hippocampal volume among nondemented APOE 3", 3 subjects, 2012, pp.7, e34292~
40. Parikh V, "Differential effects of antipsychotics on expression of antioxidant enzymes and membrane lipid peroxidation in rat brain", J Psychiatr Res, 37, pp.43~51 (2003)
41. Miljević Č, "Effect of atypical antipsychotics on antioxidant enzyme activities in human erythrocytes(in vitro study)", Hum Psychopharmacol, 28, pp.1~6 (2013)
42. Brinholi FF, "Clozapine and olanzapine are better antioxidants than haloperidol, quetiapine, risperidone and ziprasidone in in vitro models", Biomed Pharmacother, 81, pp.411~415 (2016)
43. Saretzki G, "Extra-telomeric functions of human telomerase:cancer, mitochondria and oxidative stress", Curr Pharm Des, 20, pp.6386~6403 (2014)
44. Bersani FS, "Telomerase activation as a possible mechanism of action for psychopharmacological interventions", Drug Discov Today, 20, pp.1305~1309 (2015)
45. Polho GB, "Leukocyte telomere length in patients with schizophrenia : a meta-analysis", Schizophr Res, 165, pp.195~200 (2015)
46. Porton B, "Telomerase levels in schizophrenia : a preliminary study", Schizophr Res, 106, pp.242~247 (2008)
47. Li Z, "Association of telomere length and mitochondrial DNA copy number with risperidone treatment response in first-episode antipsychotic-naïve schizophrenia", Sci Rep, 5, pp.18553~ (2015)
48. Leykin I, "Short and long-term immunosuppressive effects of clozapine and haloperidol", Immunopharmacology, 37, pp.75~86 (1997)
49. Craddock RM, "Altered T-cell function in schizophrenia : a cellular model to investigate molecular disease mechanisms", PLoS One, 2, pp.692~ (2007)
50. Gladkevich A, "Lymphocytes as a neural probe : potential for studying psychiatric disorders", Prog Neuropsychopharmacol Biol Psychiatry, 28, pp.559~576 (2004)
51. Lin J, "Telomeres and lifestyle factors : roles in cellular aging", Mutat Res, 730, pp.85~89 (2012)
52. Østhus IB, "Telomere length and long-term endurance exercise: does exercise training affect biological age? A pilot study", PLoS One, 7, pp.e52769~ (2012)
53. Dipasquale S, "The dietary pattern of patients with schizophrenia : a systematic review", J Psychiatr Res, 47, pp.197~207 (2013)
54. Weng NP, "Human naive and memory T lymphocytes differ in telomeric length and replicative potential", Proc Natl Acad Sci U S A, 92, pp.11091~11094 (1995)
55. Drexhage RC, "An activated set point of T-cell and monocyte inflammatory networks in recentonset schizophrenia patients involves both pro-and antiinflammatory forces", Int J Neuropsychopharmacol, 14, pp.746~755 (2011)
56. Fernandez-Egea E, "Peripheral immune cell populations associated with cognitive deficits and negative symptoms of treatment-resistant schizophrenia", PLoS One, 11, pp.e0155631~ (2016)

관련 논문AI추천